Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112M Sell
370,140
-18,140
-5% -$3.6M 0.85% 22
2026
Q1
$57.2M Sell
388,280
-126,820
-25% -$18.6M 0.47% 75
2025
Q4
$62.6M Sell
515,100
-19,220
-4% -$2.25M 0.47% 76
2025
Q3
$57.6M Sell
534,320
-65,720
-11% -$6.13M 0.42% 93
2025
Q2
$53.7M Buy
600,040
+103,180
+21% +$7.76M 0.38% 105
2025
Q1
$33.8M Buy
496,860
+11,190
+2% +$806K 0.25% 152
2024
Q4
$30.6M Sell
485,670
-2,020
-0.4% -$137K 0.21% 159
2024
Q3
$37.8M Sell
487,690
-128,830
-21% -$10.1M 0.26% 148
2024
Q2
$50.8M Buy
616,520
+39,570
+7% +$2.92M 0.38% 109
2024
Q1
$40.3M Buy
+576,950
New +$37.1M 0.29% 129

Other funds holding KLAC

Boston Trust Walden's KLAC Position: Q2 2026 in Review

Boston Trust Walden reduced its KLA (KLAC) stake by 4.7% in Q2 2026, selling an estimated $3.6M and leaving 370,140 shares worth $112M. The position accounts for 0.85% of the portfolio, ranked #22.

Boston Trust Walden first reported a position in KLAC in Q1 2024 and has held it in 10 quarters since. 2,481 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Boston Trust Walden held 370,140 shares of KLA worth $112M as of Q2 2026.
  • Boston Trust Walden sold 18,140 KLA shares in Q2 2026, an estimated $3.6M.
  • KLA made up 0.85% of Boston Trust Walden's portfolio in Q2 2026, its #22 holding.
  • Boston Trust Walden first reported a position in KLA in Q1 2024 and has held it in 10 quarters since.
  • 2,481 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.